Professional Documents
Culture Documents
Megan Reitzel
Scientific paper
Biology 1615-Greg Wahlert
Megan Reitzel
Scientific Paper
Biology 1615-Greg Wahlert
(CCHD) which go undiagnosed until it is too late for the child. The objective of this
experiment was to estimate the number of infants with CCHDs in the United States
whom could be detected and not undiagnosed, if there was a universal newborn CCHD
screening. Newborn screening for CCHD has been implemented in many hospitals
however there is uncertainty about the number of children with CCHD that might be
detected if there was a universal implement of newborn CCHD screening in the United
States.
A study done by Dr. Aile had developed a stimulation model based on estimates
of birth prevalence, prenatal diagnoses, late detection, and sensitivity of newborns with
CCHD through the use of a pulse oximetry (it tests the oxygen saturation in the blood)
to find the true positives and false negatives cases of primary and secondary CCHD
screening. They combined COA (coarctation of the aorta) and IAA (Interrupted aortic
arch) to one category and all other CCHD into another category, named multiple CCHD.
They only included children under the age of one whom were diagnosed. The study only
detection was most common for COA/IAA. It was estimated that 5,965 infants are born
alive with CCHD, annually in the United States; however, TOF, COA/IAA, d-TAG, and
HLHS accounted for seventy-five percent of the cases of CCHD. After using a pulse
oximetry, they would detect 875 infants with CCHD with 15 percent of those being false
negatives. The pulse oximetry has the greatest benefit in detecting CCHD in case of
TAPVR, and COA/IAA with a detection rate as high as twenty to thirty percent.
In the secondary study assuming low prenatal detection the estimated number of
true positives was 1105 and 1020 false negatives would result with a pulse oximeter. In
high prenatal detection 740 true positives and 785 false negatives would result. which is
The estimated number of infants with CCHD that could be detected annually in
the United States is 900; however, because of high birth prevalence another 900 infant
cases of CCHD could be missed using a pulse oximetry. In the first study. In the second
study with low birth prevalence (19% VS 41%) the difference in infants with
undiagnosed CCHD at birth goes down by timely diagnoses. Meaning, through this
model 900 infants per year with CCHD are likely to be detected through a universal
CCHD screening in the united states; however, there is an equal number that would get
false negatives leaving the general practitioner to not solely rely on the screening of
CCHD.
With the results of this study it shows that while using a pulse oximetry it could
prevent children going undiagnosed with CCHD, there is still a long way to go to find a
universal test for children that could have CCHD that has more true-positives then
equaling the false-negatives. This also shows that each test can get different results
research a universal test that could potentially lead to higher detection rate for CCHD
with not as many false-negatives. For the time being while using a pulse oximetry will
Ailes, E. C., Gilboa, S. M., Honein, M. A., & Oster, M. E. (2015, May 01). Estimated
http://pediatrics.aappublications.org/content/early/2015/05/06/peds.2014-3662
Original study
http://pediatrics.aappublications.org/content/early/2015/05/06/peds.2014-3662